A 2026 informational consumer research report examining the TMates telehealth weight-loss platform, compounded GLP-1 medication access, pricing structure, provider-pharmacy separation, and ...

Novo Nordisk is dismissing its patent infringement lawsuit against telehealth company Hims & Hers, as the two companies have reached an agreement that will see Novo Nordisk’s branded weight loss ...

Four out of five adults in Florida who need addiction treatment go without care. The Haven Detox - Florida urges people ...

Arizona-based inpatient program provides medically supervised sertraline tapering with holistic neuro-chemical ...

The government wants to ban care nationwide, and hospitals are shutting down treatment. Parents just want it all to stop.

The AHA has published a scientific statement regarding the screening, diagnosis, and management of hypertriglyceridemia in pediatric patients.

Novo Nordisk has dismissed its patent infringement lawsuit against telehealth provider Hims & Hers, following an agreement that will see the pharmaceutical giant’s branded weight loss medications sold ...

The most obvious and most devastating impact of these cuts to the program is the immediate death left in their wake. As Oliver explains, these are not abstract numbers, but specific people. The host ...

Omada Health hit a key profitability milestone at the end of 2025 as it brought in net income of $5 million in the fourth quarter, its first profitable quarter. | To make further inroads into the ...

Novo Nordisk drops lawsuit over weight loss medications, enters collaboration with online pharmacy - The news sent shares of ...

Amazon Pharmacy (NASDAQ:AMZN) said it has begun offering Eli Lilly’s Zepbound KwikPen, a multi-dose injectable medication for weight management, with cash-pay pricing starting at $299 per month for ...